nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.147	0.519	CrCtD
Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.136	0.481	CrCtD
Idarubicin—Topoisomerase Inhibitors—Topotecan—peripheral nervous system neoplasm	0.0898	0.236	CiPCiCtD
Idarubicin—Anthracyclines—Epirubicin—peripheral nervous system neoplasm	0.0788	0.207	CiPCiCtD
Idarubicin—Anthracyclines—Doxorubicin—peripheral nervous system neoplasm	0.073	0.192	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Etoposide—peripheral nervous system neoplasm	0.0599	0.157	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Epirubicin—peripheral nervous system neoplasm	0.0412	0.108	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Doxorubicin—peripheral nervous system neoplasm	0.0381	0.1	CiPCiCtD
Idarubicin—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.0313	0.173	CrCrCtD
Idarubicin—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.0313	0.173	CrCrCtD
Idarubicin—Valrubicin—Epirubicin—peripheral nervous system neoplasm	0.0313	0.173	CrCrCtD
Idarubicin—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.029	0.16	CrCrCtD
Idarubicin—Valrubicin—Doxorubicin—peripheral nervous system neoplasm	0.029	0.16	CrCrCtD
Idarubicin—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.029	0.16	CrCrCtD
Idarubicin—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.0212	0.19	CbGbCtD
Idarubicin—TOP2A—Etoposide—peripheral nervous system neoplasm	0.0165	0.148	CbGbCtD
Idarubicin—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0162	0.146	CbGbCtD
Idarubicin—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0118	0.105	CbGbCtD
Idarubicin—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.0113	0.101	CbGbCtD
Idarubicin—ABCC1—Vincristine—peripheral nervous system neoplasm	0.01	0.0896	CbGbCtD
Idarubicin—ABCC1—Etoposide—peripheral nervous system neoplasm	0.00916	0.0821	CbGbCtD
Idarubicin—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.00625	0.056	CbGbCtD
Idarubicin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.00541	0.0485	CbGbCtD
Idarubicin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00232	0.0208	CbGbCtD
Idarubicin—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.0127	CbGbCtD
Idarubicin—Epirubicin—AURKA—peripheral nervous system neoplasm	0.000694	0.581	CrCbGaD
Idarubicin—Doxorubicin—AURKA—peripheral nervous system neoplasm	0.000399	0.334	CrCbGaD
Idarubicin—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000206	0.268	CbGdCrCtD
Idarubicin—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000122	0.159	CbGdCrCtD
Idarubicin—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	7.72e-05	0.101	CbGdCrCtD
Idarubicin—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	7.72e-05	0.1	CbGdCrCtD
Idarubicin—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	7.72e-05	0.1	CbGdCrCtD
Idarubicin—Daunorubicin—ABCB1—peripheral nervous system neoplasm	5.61e-05	0.047	CrCbGaD
Idarubicin—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	5.31e-05	0.0691	CbGdCrCtD
Idarubicin—Doxorubicin—ABCB1—peripheral nervous system neoplasm	4.56e-05	0.0381	CrCbGaD
Idarubicin—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.0524	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.0524	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.0485	CbGdCrCtD
Idarubicin—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.0485	CbGdCrCtD
Idarubicin—Alopecia—Vincristine—peripheral nervous system neoplasm	3.44e-05	0.000811	CcSEcCtD
Idarubicin—Stomatitis—Etoposide—peripheral nervous system neoplasm	3.43e-05	0.000807	CcSEcCtD
Idarubicin—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	3.4e-05	0.000801	CcSEcCtD
Idarubicin—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	3.4e-05	0.0008	CcSEcCtD
Idarubicin—Colitis—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000796	CcSEcCtD
Idarubicin—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	3.38e-05	0.000795	CcSEcCtD
Idarubicin—Atrioventricular block—Doxorubicin—peripheral nervous system neoplasm	3.36e-05	0.000791	CcSEcCtD
Idarubicin—Decreased appetite—Topotecan—peripheral nervous system neoplasm	3.32e-05	0.000782	CcSEcCtD
Idarubicin—Blood uric acid increased—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.000782	CcSEcCtD
Idarubicin—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	3.29e-05	0.000776	CcSEcCtD
Idarubicin—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	3.29e-05	0.000776	CcSEcCtD
Idarubicin—Anaemia—Alitretinoin—peripheral nervous system neoplasm	3.25e-05	0.000766	CcSEcCtD
Idarubicin—Decreased appetite—Melphalan—peripheral nervous system neoplasm	3.25e-05	0.000766	CcSEcCtD
Idarubicin—Oesophagitis—Epirubicin—peripheral nervous system neoplasm	3.22e-05	0.000758	CcSEcCtD
Idarubicin—Flushing—Cisplatin—peripheral nervous system neoplasm	3.2e-05	0.000753	CcSEcCtD
Idarubicin—Neoplasm—Epirubicin—peripheral nervous system neoplasm	3.18e-05	0.00075	CcSEcCtD
Idarubicin—Anaemia—Vincristine—peripheral nervous system neoplasm	3.13e-05	0.000738	CcSEcCtD
Idarubicin—Colitis—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000737	CcSEcCtD
Idarubicin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	3.12e-05	0.000736	CcSEcCtD
Idarubicin—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	3.12e-05	0.000734	CcSEcCtD
Idarubicin—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	3.11e-05	0.000733	CcSEcCtD
Idarubicin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	3.1e-05	0.00073	CcSEcCtD
Idarubicin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	3.1e-05	0.00073	CcSEcCtD
Idarubicin—Urethral disorder—Etoposide—peripheral nervous system neoplasm	3.09e-05	0.000728	CcSEcCtD
Idarubicin—Infection—Dactinomycin—peripheral nervous system neoplasm	3.08e-05	0.000725	CcSEcCtD
Idarubicin—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	3.08e-05	0.000725	CcSEcCtD
Idarubicin—Sepsis—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.00072	CcSEcCtD
Idarubicin—Convulsion—Alitretinoin—peripheral nervous system neoplasm	3.05e-05	0.000718	CcSEcCtD
Idarubicin—Alopecia—Cisplatin—peripheral nervous system neoplasm	3.04e-05	0.000717	CcSEcCtD
Idarubicin—Leukopenia—Vincristine—peripheral nervous system neoplasm	3.04e-05	0.000715	CcSEcCtD
Idarubicin—Urticaria—Topotecan—peripheral nervous system neoplasm	3.03e-05	0.000715	CcSEcCtD
Idarubicin—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	3.03e-05	0.000714	CcSEcCtD
Idarubicin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	3.02e-05	0.000711	CcSEcCtD
Idarubicin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	3.02e-05	0.000711	CcSEcCtD
Idarubicin—Urticaria—Tretinoin—peripheral nervous system neoplasm	3.01e-05	0.000709	CcSEcCtD
Idarubicin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	3.01e-05	0.000709	CcSEcCtD
Idarubicin—Malnutrition—Cisplatin—peripheral nervous system neoplasm	3e-05	0.000706	CcSEcCtD
Idarubicin—Chest pain—Alitretinoin—peripheral nervous system neoplasm	3e-05	0.000706	CcSEcCtD
Idarubicin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	3e-05	0.000706	CcSEcCtD
Idarubicin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	3e-05	0.000706	CcSEcCtD
Idarubicin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	3e-05	0.000706	CcSEcCtD
Idarubicin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	3e-05	0.000706	CcSEcCtD
Idarubicin—Oesophagitis—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	0.000701	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	2.98e-05	0.000701	CcSEcCtD
Idarubicin—Urticaria—Melphalan—peripheral nervous system neoplasm	2.97e-05	0.0007	CcSEcCtD
Idarubicin—Phlebitis—Epirubicin—peripheral nervous system neoplasm	2.97e-05	0.000699	CcSEcCtD
Idarubicin—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	2.95e-05	0.000696	CcSEcCtD
Idarubicin—Anorexia—Dactinomycin—peripheral nervous system neoplasm	2.95e-05	0.000695	CcSEcCtD
Idarubicin—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.000694	CcSEcCtD
Idarubicin—Convulsion—Vincristine—peripheral nervous system neoplasm	2.94e-05	0.000692	CcSEcCtD
Idarubicin—Flushing—Etoposide—peripheral nervous system neoplasm	2.93e-05	0.00069	CcSEcCtD
Idarubicin—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.000689	CcSEcCtD
Idarubicin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	2.87e-05	0.000676	CcSEcCtD
Idarubicin—Angiopathy—Etoposide—peripheral nervous system neoplasm	2.86e-05	0.000674	CcSEcCtD
Idarubicin—Infection—Alitretinoin—peripheral nervous system neoplasm	2.85e-05	0.000672	CcSEcCtD
Idarubicin—Immune system disorder—Etoposide—peripheral nervous system neoplasm	2.85e-05	0.000671	CcSEcCtD
Idarubicin—Chills—Etoposide—peripheral nervous system neoplasm	2.83e-05	0.000667	CcSEcCtD
Idarubicin—Sepsis—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000666	CcSEcCtD
Idarubicin—Shock—Alitretinoin—peripheral nervous system neoplasm	2.83e-05	0.000665	CcSEcCtD
Idarubicin—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000664	CcSEcCtD
Idarubicin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	2.81e-05	0.000663	CcSEcCtD
Idarubicin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	2.81e-05	0.000662	CcSEcCtD
Idarubicin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	2.79e-05	0.000658	CcSEcCtD
Idarubicin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	2.79e-05	0.000658	CcSEcCtD
Idarubicin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	2.79e-05	0.000657	CcSEcCtD
Idarubicin—Alopecia—Etoposide—peripheral nervous system neoplasm	2.79e-05	0.000657	CcSEcCtD
Idarubicin—Anaemia—Cisplatin—peripheral nervous system neoplasm	2.77e-05	0.000653	CcSEcCtD
Idarubicin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	2.77e-05	0.000652	CcSEcCtD
Idarubicin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	2.76e-05	0.000649	CcSEcCtD
Idarubicin—Infection—Vincristine—peripheral nervous system neoplasm	2.75e-05	0.000647	CcSEcCtD
Idarubicin—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000647	CcSEcCtD
Idarubicin—Anorexia—Alitretinoin—peripheral nervous system neoplasm	2.74e-05	0.000645	CcSEcCtD
Idarubicin—Hot flush—Epirubicin—peripheral nervous system neoplasm	2.73e-05	0.000644	CcSEcCtD
Idarubicin—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	2.73e-05	0.000644	CcSEcCtD
Idarubicin—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	2.71e-05	0.000638	CcSEcCtD
Idarubicin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	2.71e-05	0.000638	CcSEcCtD
Idarubicin—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000638	CcSEcCtD
Idarubicin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	2.69e-05	0.000634	CcSEcCtD
Idarubicin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	2.68e-05	0.000632	CcSEcCtD
Idarubicin—Anorexia—Vincristine—peripheral nervous system neoplasm	2.64e-05	0.000621	CcSEcCtD
Idarubicin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	2.61e-05	0.000616	CcSEcCtD
Idarubicin—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000614	CcSEcCtD
Idarubicin—Convulsion—Cisplatin—peripheral nervous system neoplasm	2.6e-05	0.000612	CcSEcCtD
Idarubicin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	2.59e-05	0.000611	CcSEcCtD
Idarubicin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	2.59e-05	0.000611	CcSEcCtD
Idarubicin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	2.56e-05	0.000603	CcSEcCtD
Idarubicin—Anaemia—Etoposide—peripheral nervous system neoplasm	2.54e-05	0.000598	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	2.54e-05	0.000597	CcSEcCtD
Idarubicin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	2.53e-05	0.000597	CcSEcCtD
Idarubicin—Hot flush—Doxorubicin—peripheral nervous system neoplasm	2.53e-05	0.000596	CcSEcCtD
Idarubicin—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.00059	CcSEcCtD
Idarubicin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	2.5e-05	0.000588	CcSEcCtD
Idarubicin—Leukopenia—Etoposide—peripheral nervous system neoplasm	2.46e-05	0.000579	CcSEcCtD
Idarubicin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	2.45e-05	0.000577	CcSEcCtD
Idarubicin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	2.45e-05	0.000577	CcSEcCtD
Idarubicin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	2.45e-05	0.000576	CcSEcCtD
Idarubicin—Infection—Cisplatin—peripheral nervous system neoplasm	2.43e-05	0.000573	CcSEcCtD
Idarubicin—Vomiting—Topotecan—peripheral nervous system neoplasm	2.43e-05	0.000572	CcSEcCtD
Idarubicin—Vomiting—Tretinoin—peripheral nervous system neoplasm	2.41e-05	0.000567	CcSEcCtD
Idarubicin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	2.41e-05	0.000567	CcSEcCtD
Idarubicin—Rash—Topotecan—peripheral nervous system neoplasm	2.41e-05	0.000567	CcSEcCtD
Idarubicin—Dermatitis—Topotecan—peripheral nervous system neoplasm	2.41e-05	0.000567	CcSEcCtD
Idarubicin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	2.41e-05	0.000567	CcSEcCtD
Idarubicin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	2.4e-05	0.000564	CcSEcCtD
Idarubicin—Headache—Topotecan—peripheral nervous system neoplasm	2.39e-05	0.000564	CcSEcCtD
Idarubicin—Rash—Tretinoin—peripheral nervous system neoplasm	2.39e-05	0.000563	CcSEcCtD
Idarubicin—Rash—Isotretinoin—peripheral nervous system neoplasm	2.39e-05	0.000563	CcSEcCtD
Idarubicin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	2.39e-05	0.000562	CcSEcCtD
Idarubicin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	2.39e-05	0.000562	CcSEcCtD
Idarubicin—Convulsion—Etoposide—peripheral nervous system neoplasm	2.38e-05	0.00056	CcSEcCtD
Idarubicin—Vomiting—Melphalan—peripheral nervous system neoplasm	2.38e-05	0.00056	CcSEcCtD
Idarubicin—Dehydration—Epirubicin—peripheral nervous system neoplasm	2.38e-05	0.00056	CcSEcCtD
Idarubicin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	2.38e-05	0.00056	CcSEcCtD
Idarubicin—Headache—Isotretinoin—peripheral nervous system neoplasm	2.37e-05	0.000559	CcSEcCtD
Idarubicin—Headache—Tretinoin—peripheral nervous system neoplasm	2.37e-05	0.000559	CcSEcCtD
Idarubicin—Rash—Melphalan—peripheral nervous system neoplasm	2.36e-05	0.000555	CcSEcCtD
Idarubicin—Dermatitis—Melphalan—peripheral nervous system neoplasm	2.36e-05	0.000555	CcSEcCtD
Idarubicin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	2.35e-05	0.000553	CcSEcCtD
Idarubicin—Chest pain—Etoposide—peripheral nervous system neoplasm	2.34e-05	0.000551	CcSEcCtD
Idarubicin—Anorexia—Cisplatin—peripheral nervous system neoplasm	2.33e-05	0.000549	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	2.32e-05	0.000547	CcSEcCtD
Idarubicin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	2.28e-05	0.000537	CcSEcCtD
Idarubicin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	2.28e-05	0.000537	CcSEcCtD
Idarubicin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	2.27e-05	0.000535	CcSEcCtD
Idarubicin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	2.27e-05	0.000535	CcSEcCtD
Idarubicin—Nausea—Topotecan—peripheral nervous system neoplasm	2.27e-05	0.000534	CcSEcCtD
Idarubicin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	2.26e-05	0.000533	CcSEcCtD
Idarubicin—Nausea—Tretinoin—peripheral nervous system neoplasm	2.25e-05	0.00053	CcSEcCtD
Idarubicin—Nausea—Isotretinoin—peripheral nervous system neoplasm	2.25e-05	0.00053	CcSEcCtD
Idarubicin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	2.24e-05	0.000528	CcSEcCtD
Idarubicin—Infection—Etoposide—peripheral nervous system neoplasm	2.23e-05	0.000525	CcSEcCtD
Idarubicin—Nausea—Melphalan—peripheral nervous system neoplasm	2.22e-05	0.000523	CcSEcCtD
Idarubicin—Dehydration—Doxorubicin—peripheral nervous system neoplasm	2.2e-05	0.000518	CcSEcCtD
Idarubicin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	2.19e-05	0.000517	CcSEcCtD
Idarubicin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	2.19e-05	0.000515	CcSEcCtD
Idarubicin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	2.19e-05	0.000515	CcSEcCtD
Idarubicin—Skin disorder—Etoposide—peripheral nervous system neoplasm	2.18e-05	0.000513	CcSEcCtD
Idarubicin—Anorexia—Etoposide—peripheral nervous system neoplasm	2.14e-05	0.000503	CcSEcCtD
Idarubicin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	2.13e-05	0.000501	CcSEcCtD
Idarubicin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	2.12e-05	0.000499	CcSEcCtD
Idarubicin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	2.12e-05	0.000498	CcSEcCtD
Idarubicin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	2.1e-05	0.000494	CcSEcCtD
Idarubicin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	2.07e-05	0.000487	CcSEcCtD
Idarubicin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	2.04e-05	0.00048	CcSEcCtD
Idarubicin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	1.97e-05	0.000464	CcSEcCtD
Idarubicin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	1.97e-05	0.000463	CcSEcCtD
Idarubicin—Rash—Dactinomycin—peripheral nervous system neoplasm	1.95e-05	0.00046	CcSEcCtD
Idarubicin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	1.95e-05	0.000459	CcSEcCtD
Idarubicin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	1.94e-05	0.000457	CcSEcCtD
Idarubicin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	1.93e-05	0.000456	CcSEcCtD
Idarubicin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	1.92e-05	0.000452	CcSEcCtD
Idarubicin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	1.91e-05	0.00045	CcSEcCtD
Idarubicin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	1.89e-05	0.000446	CcSEcCtD
Idarubicin—Nausea—Dactinomycin—peripheral nervous system neoplasm	1.84e-05	0.000433	CcSEcCtD
Idarubicin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	1.83e-05	0.000432	CcSEcCtD
Idarubicin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	1.83e-05	0.00043	CcSEcCtD
Idarubicin—Rash—Alitretinoin—peripheral nervous system neoplasm	1.81e-05	0.000426	CcSEcCtD
Idarubicin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	1.81e-05	0.000426	CcSEcCtD
Idarubicin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	1.8e-05	0.000425	CcSEcCtD
Idarubicin—Headache—Alitretinoin—peripheral nervous system neoplasm	1.8e-05	0.000424	CcSEcCtD
Idarubicin—Urticaria—Etoposide—peripheral nervous system neoplasm	1.78e-05	0.000419	CcSEcCtD
Idarubicin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	1.78e-05	0.000419	CcSEcCtD
Idarubicin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	1.78e-05	0.000419	CcSEcCtD
Idarubicin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	1.77e-05	0.000417	CcSEcCtD
Idarubicin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	1.77e-05	0.000417	CcSEcCtD
Idarubicin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	1.77e-05	0.000417	CcSEcCtD
Idarubicin—Vomiting—Vincristine—peripheral nervous system neoplasm	1.76e-05	0.000414	CcSEcCtD
Idarubicin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	1.75e-05	0.000411	CcSEcCtD
Idarubicin—Rash—Vincristine—peripheral nervous system neoplasm	1.74e-05	0.000411	CcSEcCtD
Idarubicin—Dermatitis—Vincristine—peripheral nervous system neoplasm	1.74e-05	0.000411	CcSEcCtD
Idarubicin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	1.73e-05	0.000408	CcSEcCtD
Idarubicin—Headache—Vincristine—peripheral nervous system neoplasm	1.73e-05	0.000408	CcSEcCtD
Idarubicin—Nausea—Alitretinoin—peripheral nervous system neoplasm	1.71e-05	0.000402	CcSEcCtD
Idarubicin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	1.67e-05	0.000394	CcSEcCtD
Idarubicin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	1.65e-05	0.000389	CcSEcCtD
Idarubicin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	1.64e-05	0.000387	CcSEcCtD
Idarubicin—Nausea—Vincristine—peripheral nervous system neoplasm	1.64e-05	0.000387	CcSEcCtD
Idarubicin—Flushing—Epirubicin—peripheral nervous system neoplasm	1.64e-05	0.000387	CcSEcCtD
Idarubicin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	1.64e-05	0.000385	CcSEcCtD
Idarubicin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	1.62e-05	0.000381	CcSEcCtD
Idarubicin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	1.6e-05	0.000378	CcSEcCtD
Idarubicin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	1.6e-05	0.000378	CcSEcCtD
Idarubicin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	1.6e-05	0.000376	CcSEcCtD
Idarubicin—Chills—Epirubicin—peripheral nervous system neoplasm	1.59e-05	0.000374	CcSEcCtD
Idarubicin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	1.58e-05	0.000372	CcSEcCtD
Idarubicin—Alopecia—Epirubicin—peripheral nervous system neoplasm	1.56e-05	0.000368	CcSEcCtD
Idarubicin—Vomiting—Cisplatin—peripheral nervous system neoplasm	1.56e-05	0.000366	CcSEcCtD
Idarubicin—Rash—Cisplatin—peripheral nervous system neoplasm	1.54e-05	0.000363	CcSEcCtD
Idarubicin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	1.54e-05	0.000363	CcSEcCtD
Idarubicin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	1.54e-05	0.000363	CcSEcCtD
Idarubicin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	1.53e-05	0.000361	CcSEcCtD
Idarubicin—Flushing—Doxorubicin—peripheral nervous system neoplasm	1.52e-05	0.000358	CcSEcCtD
Idarubicin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	1.48e-05	0.00035	CcSEcCtD
Idarubicin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	1.48e-05	0.000348	CcSEcCtD
Idarubicin—Chills—Doxorubicin—peripheral nervous system neoplasm	1.47e-05	0.000346	CcSEcCtD
Idarubicin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	1.46e-05	0.000344	CcSEcCtD
Idarubicin—Nausea—Cisplatin—peripheral nervous system neoplasm	1.45e-05	0.000342	CcSEcCtD
Idarubicin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	1.45e-05	0.000341	CcSEcCtD
Idarubicin—Vomiting—Etoposide—peripheral nervous system neoplasm	1.43e-05	0.000336	CcSEcCtD
Idarubicin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	1.42e-05	0.000336	CcSEcCtD
Idarubicin—Anaemia—Epirubicin—peripheral nervous system neoplasm	1.42e-05	0.000335	CcSEcCtD
Idarubicin—Rash—Etoposide—peripheral nervous system neoplasm	1.41e-05	0.000333	CcSEcCtD
Idarubicin—Dermatitis—Etoposide—peripheral nervous system neoplasm	1.41e-05	0.000333	CcSEcCtD
Idarubicin—Headache—Etoposide—peripheral nervous system neoplasm	1.4e-05	0.000331	CcSEcCtD
Idarubicin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	1.38e-05	0.000325	CcSEcCtD
Idarubicin—Convulsion—Epirubicin—peripheral nervous system neoplasm	1.33e-05	0.000314	CcSEcCtD
Idarubicin—Nausea—Etoposide—peripheral nervous system neoplasm	1.33e-05	0.000314	CcSEcCtD
Idarubicin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	1.32e-05	0.00031	CcSEcCtD
Idarubicin—Chest pain—Epirubicin—peripheral nervous system neoplasm	1.31e-05	0.000309	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	1.3e-05	0.000307	CcSEcCtD
Idarubicin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	1.28e-05	0.0003	CcSEcCtD
Idarubicin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	1.26e-05	0.000296	CcSEcCtD
Idarubicin—Infection—Epirubicin—peripheral nervous system neoplasm	1.25e-05	0.000294	CcSEcCtD
Idarubicin—Shock—Epirubicin—peripheral nervous system neoplasm	1.24e-05	0.000291	CcSEcCtD
Idarubicin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	1.23e-05	0.000291	CcSEcCtD
Idarubicin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	1.23e-05	0.00029	CcSEcCtD
Idarubicin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	1.22e-05	0.000287	CcSEcCtD
Idarubicin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	1.21e-05	0.000286	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	1.2e-05	0.000284	CcSEcCtD
Idarubicin—Anorexia—Epirubicin—peripheral nervous system neoplasm	1.2e-05	0.000282	CcSEcCtD
Idarubicin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	1.16e-05	0.000274	CcSEcCtD
Idarubicin—Infection—Doxorubicin—peripheral nervous system neoplasm	1.16e-05	0.000272	CcSEcCtD
Idarubicin—Shock—Doxorubicin—peripheral nervous system neoplasm	1.14e-05	0.000269	CcSEcCtD
Idarubicin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	1.14e-05	0.000268	CcSEcCtD
Idarubicin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	1.13e-05	0.000266	CcSEcCtD
Idarubicin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	1.11e-05	0.000261	CcSEcCtD
Idarubicin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	1.09e-05	0.000257	CcSEcCtD
Idarubicin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	1.03e-05	0.000242	CcSEcCtD
Idarubicin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	1.01e-05	0.000238	CcSEcCtD
Idarubicin—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.98e-06	0.000235	CcSEcCtD
Idarubicin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.93e-06	0.000234	CcSEcCtD
Idarubicin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.93e-06	0.000234	CcSEcCtD
Idarubicin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.51e-06	0.000224	CcSEcCtD
Idarubicin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.26e-06	0.000218	CcSEcCtD
Idarubicin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.24e-06	0.000218	CcSEcCtD
Idarubicin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.19e-06	0.000216	CcSEcCtD
Idarubicin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.19e-06	0.000216	CcSEcCtD
Idarubicin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.6e-06	0.000202	CcSEcCtD
Idarubicin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.57e-06	0.000202	CcSEcCtD
Idarubicin—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.99e-06	0.000188	CcSEcCtD
Idarubicin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.96e-06	0.000187	CcSEcCtD
Idarubicin—Rash—Epirubicin—peripheral nervous system neoplasm	7.92e-06	0.000187	CcSEcCtD
Idarubicin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.92e-06	0.000186	CcSEcCtD
Idarubicin—Headache—Epirubicin—peripheral nervous system neoplasm	7.87e-06	0.000185	CcSEcCtD
Idarubicin—Nausea—Epirubicin—peripheral nervous system neoplasm	7.46e-06	0.000176	CcSEcCtD
Idarubicin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.39e-06	0.000174	CcSEcCtD
Idarubicin—Rash—Doxorubicin—peripheral nervous system neoplasm	7.33e-06	0.000173	CcSEcCtD
Idarubicin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.32e-06	0.000172	CcSEcCtD
Idarubicin—Headache—Doxorubicin—peripheral nervous system neoplasm	7.28e-06	0.000172	CcSEcCtD
Idarubicin—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.91e-06	0.000163	CcSEcCtD
